| __timestamp | ADMA Biologics, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 72429000 |
| Thursday, January 1, 2015 | 6745968 | 78634000 |
| Friday, January 1, 2016 | 8494742 | 75374000 |
| Sunday, January 1, 2017 | 18092835 | 92157000 |
| Monday, January 1, 2018 | 22502922 | 93326000 |
| Tuesday, January 1, 2019 | 25910757 | 103132000 |
| Wednesday, January 1, 2020 | 35050817 | 110171000 |
| Friday, January 1, 2021 | 42896889 | 218817000 |
| Saturday, January 1, 2022 | 52458024 | 233827000 |
| Sunday, January 1, 2023 | 59020000 | 267194000 |
Data in motion
In the competitive landscape of biotechnology, effective cost management is crucial. Over the past decade, Lantheus Holdings, Inc. and ADMA Biologics, Inc. have demonstrated contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Lantheus Holdings saw a steady increase in SG&A expenses, peaking at approximately $267 million in 2023, reflecting a 270% rise from 2014. This growth underscores their aggressive expansion and investment in operational capabilities. Meanwhile, ADMA Biologics, Inc. experienced a more moderate increase, with expenses growing by nearly 1,100% over the same period, reaching around $59 million in 2023. This significant rise highlights their strategic focus on scaling operations and market penetration. Understanding these trends offers valuable insights into how these companies balance growth and cost efficiency in a rapidly evolving industry.
SG&A Efficiency Analysis: Comparing Johnson & Johnson and ADMA Biologics, Inc.
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs ADMA Biologics, Inc.
Insmed Incorporated vs Lantheus Holdings, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Verona Pharma plc Trends and Insights
Lantheus Holdings, Inc. vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Geron Corporation
SG&A Efficiency Analysis: Comparing Lantheus Holdings, Inc. and MiMedx Group, Inc.
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs Evotec SE
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and Viking Therapeutics, Inc.
ADMA Biologics, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: ADMA Biologics, Inc. vs HUTCHMED (China) Limited
Comparing SG&A Expenses: ADMA Biologics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights